AusMedtech Regulatory Affairs Advisory Group
The Advisory Group represents members in the medical technology sector providing guidance and advice to AusBiotech on operational and policy-related regulatory matters regarding dealings with the Therapeutic Goods Administration (TGA). The Advisory Group provides representation through coordination of submissions to the TGA and Department of Health consultations and participation in the TGA/Industry Regulatory and Technical Consultative Forum.
Chaired by Dr Darren Forrest, Director of Quality & Regulatory Affairs ANZ, Medtronic Australasia Pty Ltd
- Yervant Chijian, Director, Team Lead Medical Devices / IVD, Australia, Cencora PharmaLex
Gibran Maher, CEO, Additive Surgical
- Dr Jeremy Paull, VP Development & Regulatory Affairs, Starpharma Pty Ltd
- Manuel Urena, Director Regulatory Affairs, APAC, Cochlear Limited